Robert
 
N.
 
Baldassano
M.D.
Email: 
baldassano@email.chop.edu
Address: 
Division of Gastroenterology and Nutrition The Children's Hospital of Philadelphia 324 S. 34th Street
215-590-5711
Affiliations
Expertise

Dr. Baldassano studies the cause of inflammatory bowel disease for the purpose of finding new treatments and to improve the quality of life for these chronically ill patients.

Appointments
Associate Professor of Pediatrics at the Children's Hospital of Philadelphia (2003 – 2007)
Professor of Pediatrics at the Children's Hospital of Philadelphia (2007– present)
Assistant Professor of Pediatrics at the Children's Hospital of Philadelphia (1996 – 2003)
Education
M.D., SUNY Health Science Center at Brooklyn, College of Medicine, New York (1984)
B.S., Mathematics, Physics, Computer Science, State University at Albany, New York (1977)
Selected Publications
Baldassano RN, Ruemmele F, Rosh J. Faubion WA, Kierkus J, Hyams JS, Lazar A, Wang Y, Eichner S, Thakkar RB.. Long-term safety of adalimumab in paediatric patients with Crohn?s disease.. United European Gastroenterology (UEG) Week Berlin 2013, Berlin, Germany. 2013 Oct 12-16.
Kierkus J, Crandall W, Hyams JS, Rosh J, Markowitz J, Baldassano RN, Lazar A, Wang Y, Eichner S, Thakkar RB.. Early response to treatment with adalimumab in children with moderately to severely active Crohn?s disease: Results from Imagine 1.. United European Gastroenterology (UEG) Week Berlin 2013, Berlin, Germany. 2013 Oct 12-16.
Griffiths A, Baldassano RN, Walters T, Bronksy J, Hyams JS, Lazar A, Wang Y, Eichner S. Thakkar RB.. Improvement in markers of bone metabolism with adalimumab in children with moderately to severely active Crohn?s disease: Results from Imagine 1.. United European Gastroenterology (UEG) Week Berlin 2013, Berlin, Germany. 2013 Oct 12-16.
Gupta Kernika, Noble Angela, Kachelries Kelly E, Albenberg Lindsey, Kelsen Judith R, Grossman Andrew B, Baldassano Robert N. A novel enteral nutrition protocol for the treatment of pediatric Crohn's disease.. Inflammatory Bowel Dis. Vol 19(7) . 2013 Jun:1374-8.
Baldassano RN, Colletti RB, Cucchiara S, Dubinsky M, Escher JC, Faubion WA, Fell J, Gold BD, Griffiths AM, Hyams JS, Koletzko S, Kugathasan S, Markowitz J, Ruemmele F, Veereman G, Callegari P, Geldhof A, Molenda MR, Wright R, Tang KL, Winter HS.. Serious infections and associated risk factors in patients receiving infliximab and immunotherapies for children with inflammatory bowel disease: DEVELOP Registry Data. American Gastroenterological Association:. American Gastroenterological Association; Digestive Disease Week 2013, Orlando, FL, May 19-21; Gastroenterology. Vol 144(5; S1) . 2013 May 19-21:S-11.
Hyams JS, Kim M, Denson L, Griffiths AM, Dubinsky M, Markowitz J, Baldassano RN, Crandall W, Rosh JR, Pfefferkorn MD, Otley AR, Heyman MB, Leleiko NS, Baker SS, Guthery SL, Evans J, Ziring D, Kellermayer R, Stephens MC, Mack DR, Oliva-Hemker M, Essers JB, Patel AS, Kirschner BS, Moulton E, Cohen SA, Liu C, Kugathasan S, Walters TD.. Early anti-TNFa therapy is superior to early immunomodulator therapy in newly diagnosed children with Crohn?s disease.. American Gastroenterological Association; Digestive Disease Week 2013, Orlando, FL, May 19-21, 2013. Gastroenterology. Vol 144(5; S1) . 2013 May:S-146.
Albenberg L, Judge CP, Esipova TV, Sinha R, Bailey AG, Bittinger K, Grunberg S, Chen J, Bhopale VM, Baldassano RN, Lewis JD, Li H, Thom SR, Bushman FD, Vinogradov S, Wu GD.. Biological oximetry using phosphorescence quenching reveals a dynamic oxygen equilibrium maintained between the gut microbiota and the host.. American Gastroenterological Association: Digestive Disease Week 2013, Orlando, FL, May 19-21, 2013. Gastroenterology. Vol 144(5; S1) . 2013 May:S-156-157.
Tsampalieros Anne, Lam Carol K L, Spencer Jenna C, Thayu Meena, Shults Justine, Zemel Babette S, Herskovitz Rita M, Baldassano Robert N, Leonard Mary B. Long Term Inflammation and Glucocorticoid Therapy Impair Skeletal Modeling during Growth in Childhood Crohn Disease.. The Journal of Clinical Endocrinology and Metabolism. 2013 May.
Kelsen JR, Posivak L, Pauly-Hubbard H, Baily AG, Bittinger K, Grunberg S, Baldassano RN, Lewis JD, Bushman FD, Wu GD.. Longitudinal characterization of the subgingival microbiota in pediatric Crohn?s disease. Poster Presentation.. American Gastroenterological Association: Digestive Disease Week 2013, Orlando, FL, May 19-21, 2013. Gastroenterology. Vol 144(5; S1) . 2013 May:S-309-310.
Colletti RB, Cucchiara S, Dubinsky M, Escher JC, Faubion WA, Fell J, Gold BD, Griffths AM, Hyams JS, Koletzko S, Kugathasan S, Winter HS, Baldassano RN, Markowitz J, Ruemmele F, Callegari P, Geldhof A, Molenda MR, Tang KL, Wright R, Veereman G.. Malignancies in children receiving infliximab and other inflammatory bowel disease therapies: An inflammatory bowel disease multicenter, prospective, long-term registry of pediatric patients (DEVELOP) registry data.. American Gastroenterological Association: Digestive Disease Week 2013, Orlando, FL, May 19-21, 2013. Gastroenterology. Vol 144(5; S1) . 2013 May:S-147.